Veri MedTech Holdings, Inc. Files Amended S-1: RSU & Capital Gains Tax Exposure Calculator (Sep 15, 2026)

What Changed

Veri MedTech Holdings filed an amended S-1 with the SEC on September 14, 2026. The 2 MB filing signals a near-term IPO in the medical technology sector. For employees holding pre-IPO equity and HNW individuals evaluating IPO allocations, lockup periods, tax treatment, and liquidity timing now carry quantifiable stakes.

The Numbers That Matter

Metric	Pre-IPO Equity Holder	IPO Allocation Buyer	Secondary Market Entry
Typical lockup period	180 days post-IPO	No lockup	No lockup
Tax treatment on sale	Long-term cap gains if held over 1 year from exercise	Short-term if sold under 1 year, long-term after	Short-term if sold under 1 year, long-term after
Liquidity constraint	Cannot sell until lockup expires	Can sell immediately	Can sell immediately
First-day volatility exposure	Full exposure, no exit	Full exposure, discretionary exit	Entry at post-volatility price

What This Means for Your Portfolio

If you hold $500K in pre-IPO Veri MedTech equity at a $12 per share strike and the IPO prices at $24, your paper gain is $500K. At the federal long-term capital gains rate of 20% plus 3.8% net investment income tax, you net $381,000 after tax. If you are subject to lockup and the stock drops 30% during that window (median first-year decline for healthcare IPOs per Renaissance Capital), your net proceeds fall to $266,700. That is a $114,300 swing based purely on timing.

Scenario Analysis

Portfolio Allocation to Veri MedTech Pre-IPO Equity	IPO Price	Lockup Expiry Price (30% decline)	After-Tax Proceeds	Opportunity Cost of Lockup
$500K at $12 strike	$24	$16.80	$266,700	$114,300
$1M at $12 strike	$24	$16.80	$533,400	$228,600
$2M at $12 strike	$24	$16.80	$1,066,800	$457,200

This table assumes you exercised ISOs or hold RSUs converting at IPO. If you hold NSOs, add ordinary income tax at exercise on the spread between strike and fair market value. For a $1M position, that is an additional $370,000 in federal tax liability at the top marginal rate of 37%, due at exercise regardless of lockup.

Frequently Asked Questions

Q: Does an S-1 amendment mean the IPO is imminent?
A: Typically within 30 to 90 days, but the SEC can extend review or request further amendments.

Q: Can I sell pre-IPO shares before the offering?
A: Only through private secondary markets, which discount illiquid equity by 20% to 40% below the expected IPO price.

Q: What is the tax difference between selling at IPO versus after lockup?
A: None if you already meet the long-term holding requirement; the rate is 23.8% either way at the federal level.

Q: Should I exercise ISOs before the IPO?
A: Factors to consider include whether the spread between strike and 409A valuation is under $100K and whether you can cover AMT. Early exercise can start your long-term holding period and potentially avoid ordinary income treatment, but this decision depends on your specific financial situation and should be evaluated with a tax professional.

Additional Considerations

If Veri MedTech prices above the preliminary range and you hold a $1M position, first-day allocation flippers in your lockup cohort will sell immediately. Median first-day IPO pop is 18% for healthcare tech per data from Jay Ritter at the University of Florida. If the stock opens at $28.32 after an 18% pop and you are locked, you watch $354,000 in paper gains erode during the 180-day window. One scenario you haven't modeled is partial early exercise. If your ISO position is $1M and you exercise $200K now at a $12 strike with a 409A of $18, you pay $22,200 in AMT this year but lock in long-term treatment on that tranche. The remaining $800K stays unexercised and converts at IPO, subjecting you to ordinary income rates on the spread.

For IPO allocations through your brokerage, you face no lockup but full first-day volatility. If you receive 2,000 shares at $24 and the stock closes at $20 on day one, you are down $8,000 before you can react. If you wait for secondary market entry post-lockup, you avoid volatility but pay the cleared price. A $500K position entered at $16.80 instead of $24 requires less upfront capital ($416,667 instead of $625,000 for the same number of shares), though the share count and final proceeds will differ based on the entry price.

Run the Numbers

Use CalcMoney's Calculate Your After-Tax RSU Proceeds to model your exact tax liability and net proceeds under both immediate sale and lockup expiry scenarios.

Disclaimer: This article is for informational purposes only and does not constitute professional financial or tax advice. Consult with a qualified tax advisor or financial professional before making decisions about exercise timing, equity holdings, or investment allocation.

Run the Numbers: Capital Gains Tax Terminal on CalcMoney — see your exact figures under current market conditions.

Data sourced from SEC EDGAR S-1 Filings (IPO). Rates and thresholds are for informational purposes only. Consult a licensed financial advisor before making mortgage, investment, or tax decisions.

Featured Partner

FIDELITY